Stacy Seng

Currently, Stacy Enxing Seng is Chairman at Contego Medical, Inc. and Cala Health, Inc. Also holds director roles at LivaNova, Inc., Fogarty Institute For Innovation, LivaNova Plc (Independent Director since 2019), Vesper Medical, Inc. (Director since 2021), Imperative Care, Inc. (Director since 2022), Fogarty Innovation LLC (Independent Director), Corza Medical Inc. (Independent Non-Executive Director since 2022), LSV Capital Management LLC (Operating Partner since 2016), and Sonova AG (Member-Supervisory Board since 2014).
Former roles include Vice Chairman at Sonova Holding AG (2021–2025), Independent Director at Hill-Rom Holdings, Inc. (2015–2021), Director at Solace Therapeutics, Inc., CV Ingenuity Corp., Claret Medical, Inc. (2018), Spirox, Inc., Fire One, Inc. (2014–2019), Go Red For Women (2014–2019), and preCARDIA, Inc. President-US Peripheral Vascular & SVP at ev3, Inc. (2009–2011), President-Vascular Therapies at Covidien Unlimited Co. (2012–2014), and Vice President-Marketing at Boston Scientific Scimed, Inc. (1999–2001).
Education includes undergraduate degree from Michigan State University (1986), MBA from Harvard Business School (1993), and graduate degree from Stanford University (2016).